Search our news, events & opinions

On 1 September 2016 Withy King LLP merged with Royds LLP. The trading name for the merged firm is Royds Withy King. All content produced prior to this date will remain in the name of the firms pre-merger.

29 March 2016 0 Comments
Posted in Corporate & Commercial, Opinion

Strategic Plan for Synthetic Biology

Author headshot image Posted by , Consultant

George Freeman MP, Minister for Life Sciences has published the UK strategic plan for synthetic biology.

The plan recognises the importance of synthetic biology to the future of the UK economy as one of the UK Governments “Eight Great Technologies” and aims to accelerate the commercial translation of products and services with clear public benefit building off the strength of the UK’s research base.

It focuses on the following five key areas of inter-related importance:

o   Accelerating industrialisation and commercialisation;

o   Maximising the capability of the innovation pipeline;

o   Building an expert workforce;

o   Developing A Supportive Business Environment; and

o   Building value from national and international partnership.

The plan highlights the recent ranking of the UK as one of the most innovative countries in the world and sets out strong recommendations for building international commercial and academic relationships with organisations in other countries with similar skills.

Link to report:

For more information on legal issues relating to the life sciences sector, please contact Thomas Bjorn.

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.




Corporate & Commercial

Our corporate lawyers will get you the right deal and protect your business, now and in the future.

Learn more


T: 020 7583 2222 (DDI)

Search our news, events & opinions